Results 251 to 260 of about 73,785 (303)

Dual direct oral anticoagulant therapy in challenging thrombosis: a case series. [PDF]

Res Pract Thromb Haemost
Chornenki NLJ, McPhaden H, Peterson EA, Benjamin Lai CM, Lee AYY.   +4 more
europepmc   +1 more source

Implementation of a Telemedicine Direct Oral Anticoagulant Monitoring Program at a Safety-Net Hospital. [PDF]

Hosp Pharm
Kaplon SC, Aqtash S, Gilbride D, Chan C, Farjo R.   +4 more
europepmc   +1 more source

Assessment of Long-Term Use Versus Discontinuation of Direct Oral Anticoagulant After Catheter Ablation for Atrial Fibrillation-RYOUMA Registry Subanalysis. [PDF]

Ann Noninvasive Electrocardiol
Oda Y, Nogami A, Komatsu Y, Soejima K, Morishima I, Hiroshima K, Kato R, Sakagami S, Miura F, Okawa K, Fukuzawa M, Takita A, Uno K, Kumagai K, Kurita T, Gosho M, Ishizu T, Aonuma K, RYOUMA Investigators.   +18 more
europepmc   +1 more source

Management of direct oral anticoagulant drug interactions in hospitalized patients. [PDF]

J Thromb Thrombolysis
Al Zaria MH, Buckley LF, Dell'orfano H, Manzo P, Fanikos J.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Direct Oral Anticoagulants

DeckerMed Critical Care of the Surgical Patient, 2017
Non–vitamin K antagonist oral anticoagulants, also known as direct oral anticoagulants, are a relatively recent class of medications introduced into clinical practice. Due to their safety profiles, fixed dosing, and lack of need for frequent laboratory monitoring, they are becoming preferred to traditional anticoagulation with warfarin in many cases of
Michael G Mount, Panna A. Codner
openaire   +2 more sources

Measuring Direct Oral Anticoagulants

2017
Direct oral anticoagulants (DOACs) can be quantified using methods that can be performed in any clinical or research laboratory using manual or automated instrument platforms. Dabigatran etexilate, the oral direct thrombin inhibitor, can be quantified by drug-calibrated clot or chromogenic-based assays using either thrombin or ecarin as substrates ...
Robert C, Gosselin, Jonathan, Douxfils
openaire   +3 more sources

New anticoagulants: Moving beyond the direct oral anticoagulants

Journal of Thrombosis and Haemostasis, 2021
Although anticoagulants have been in use for more than 80 years, heparin and vitamin K antagonists were the sole available options until recently. Although these agents revolutionized the prevention and treatment of thrombotic diseases, their use has been hampered by the necessity for coagulation monitoring and by bleeding complications resulting in ...
James C. Fredenburgh, Jeffrey I. Weitz
openaire   +2 more sources

Direct Oral Anticoagulants and Women

Seminars in Thrombosis and Hemostasis, 2016
Direct oral anticoagulants (DOACs) provide an effective, safe, and convenient therapeutic alternative to warfarin and other vitamin K antagonists (VKAs), and are now established for a wide range of indications. The use of DOACs in women merits special consideration due to two main situations: first, in relation to fertility, pregnancy, and lactation in
Cohen, Hannah, Arachchillage, Deepa R. J., Beyer-Westendorf, Jan, Middeldorp, Saskia, Kadir, Rezan A.   +4 more
openaire   +2 more sources

Direct oral anticoagulants: An update

Medicina Clínica (English Edition), 2018
Vitamin K antagonists were the only choice for chronic oral anticoagulation for more than half a century. Over the past few years, direct oral anticoagulants have emerged, including one direct thrombin inhibitor (dabigatran etexilate) and three factor Xa inhibitors (apixaban, edoxaban and rivaroxaban).
Ana Isabel, Franco Moreno, Rosa María, Martín Díaz, María José, García Navarro   +2 more
openaire   +2 more sources

Edoxaban: A direct oral anticoagulant

American Journal of Health-System Pharmacy, 2017
The pharmacology, pharmacokinetics, pharmacodynamics, clinical efficacy, safety, and place in therapy of edoxaban for prevention of stroke in patients with nonvalvular atrial fibrillation (AF) and treatment of venous thromboembolism (VTE) are reviewed.Although warfarin has been an established therapy for stroke prevention in AF and VTE, the need for ...
Mara, Poulakos, Jacqueline N, Walker, Umima, Baig, Tosin, David   +3 more
openaire   +2 more sources